NIH Director Francis Collins, MD, PhD, reported on June 10 that the first infrastructure awards supporting the RECOVER (REsearching COVID to Enhance Recover) Initiative, previously known as the Post-Acute Sequelae of SARS-CoV-2 infection (PASC) Initiative, have been allocated. These and additional awards will “ramp up research efforts and launch clinical trials to improve our understanding of this debilitating condition and identify potential treatments to help the hundreds of thousands of people who are affected,” Collins said. These awards are meant to "support infrastructure and core resource development," and thus far awardees are developing methods for monitoring protocols, including recruitment, data quality, and safety measures to identify adverse events, as well as enabling tracking and searchability of results across all sources of data, from clinical studies to electronic health records. "Building the research support infrastructure is the first step before we can launch research studies including new randomized, placebo-controlled clinical trials, which we expect to make in the weeks and months ahead,” Collins added.
